.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Citi
McKinsey
Cipla
Novartis
Fish and Richardson
Cerilliant
Colorcon
Merck

Generated: September 21, 2017

DrugPatentWatch Database Preview

Methylprednisolone sodium succinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methylprednisolone sodium succinate and what is the scope of methylprednisolone sodium succinate patent protection?

Methylprednisolone sodium succinate
is the generic ingredient in four branded drugs marketed by Elkins Sinn, Bedford Labs, Fresenius Kabi Usa, Intl Medication, Watson Labs, Hospira Inc, Organon Usa Inc, Abraxis Pharm, Amneal Pharms Co, Hospira, Pharmacia And Upjohn, Teva Parenteral, Aurobindo Pharma Ltd, Abbott, Sagent Pharms, and Hikma Farmaceutica, and is included in forty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for methylprednisolone sodium succinate. Nine suppliers are listed for this compound.

Summary for Generic Name: methylprednisolone sodium succinate

Tradenames:4
Patents:0
Applicants:16
NDAs:47
Drug Master File Entries: see list40
Suppliers / Packagers: see list9
Clinical Trials: see list2,933
Patent Applications: see list3,664
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methylprednisolone sodium succinate at DailyMed

Pharmacology for Ingredient: methylprednisolone sodium succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford Labs
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION040641-004Feb 21, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION207667-004Dec 15, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION089189-001Mar 28, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
A-METHAPRED
methylprednisolone sodium succinate
INJECTABLE;INJECTION089575-001Feb 22, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION040888-002Jul 18, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
A-METHAPRED
methylprednisolone sodium succinate
INJECTABLE;INJECTION089173-001Aug 18, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Elkins Sinn
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION086906-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION088677-001Jun 8, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION207667-002Dec 15, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Intl Medication
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION087852-001Feb 9, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Colorcon
AstraZeneca
Deloitte
Harvard Business School
Baxter
Merck
Mallinckrodt
Express Scripts
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot